{"id":"https://openalex.org/W2308167265","doi":"https://doi.org/10.1586/17474086.2016.1170593","title":"Immunotherapy approaches to treat adult acute lymphoblastic leukemia","display_name":"Immunotherapy approaches to treat adult acute lymphoblastic leukemia","publication_year":2016,"publication_date":"2016-03-24","ids":{"openalex":"https://openalex.org/W2308167265","doi":"https://doi.org/10.1586/17474086.2016.1170593","mag":"2308167265","pmid":"https://pubmed.ncbi.nlm.nih.gov/27011303"},"language":"en","primary_location":{"id":"doi:10.1586/17474086.2016.1170593","doi":"https://doi.org/10.1586/17474086.2016.1170593","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17474086.2016.1170593","pdf_url":null,"source":{"id":"https://openalex.org/S73682863","display_name":"Expert Review of Hematology","issn_l":"1747-4086","issn":["1747-4086","1747-4094"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048157024","display_name":"Elena Maino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144715","display_name":"Ospedale dell' Angelo","ror":"https://ror.org/040d6j646","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210144715"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Maino","raw_affiliation_strings":["a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","institution_ids":["https://openalex.org/I4210144715"]},{"raw_affiliation_string":"UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy","institution_ids":["https://openalex.org/I4210144715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070044155","display_name":"Massimiliano Bonifacio","orcid":"https://orcid.org/0000-0003-0716-1686","observed_orcids":["https://orcid.org/0000-0003-0716-1686"]},"institutions":[{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimiliano Bonifacio","raw_affiliation_strings":["b UOC Ematologia , Azienda Ospedaliera Universitaria Integrata, Ospedale Borgo Roma , Verona , Italy","UOC Ematologia, Azienda Ospedaliera Universitaria Integrata, Ospedale Borgo Roma, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b UOC Ematologia , Azienda Ospedaliera Universitaria Integrata, Ospedale Borgo Roma , Verona , Italy","institution_ids":["https://openalex.org/I4210094363"]},{"raw_affiliation_string":"UOC Ematologia, Azienda Ospedaliera Universitaria Integrata, Ospedale Borgo Roma, Verona, Italy","institution_ids":["https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008839925","display_name":"Anna Maria Scattolin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144715","display_name":"Ospedale dell' Angelo","ror":"https://ror.org/040d6j646","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210144715"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Maria Scattolin","raw_affiliation_strings":["a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","institution_ids":["https://openalex.org/I4210144715"]},{"raw_affiliation_string":"UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy","institution_ids":["https://openalex.org/I4210144715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004450449","display_name":"Renato Bassan","orcid":"https://orcid.org/0000-0001-8214-2894","observed_orcids":["https://orcid.org/0000-0001-8214-2894"]},"institutions":[{"id":"https://openalex.org/I4210144715","display_name":"Ospedale dell' Angelo","ror":"https://ror.org/040d6j646","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210144715"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Renato Bassan","raw_affiliation_strings":["a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a UOC Ematologia , Ospedale dell'Angelo & Ospedale SS. Giovanni e Paolo , Mestre - Venezia , Italy","institution_ids":["https://openalex.org/I4210144715"]},{"raw_affiliation_string":"UOC Ematologia, Ospedale dell\u2019Angelo & Ospedale SS. Giovanni e Paolo, Mestre \u2013 Venezia, Italy","institution_ids":["https://openalex.org/I4210144715"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004450449"],"corresponding_institution_ids":["https://openalex.org/I4210144715"],"apc_list":null,"apc_paid":null,"fwci":0.3891,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.35230084,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"9","issue":"6","first_page":"563","last_page":"577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8460000157356262},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.8930000066757202},{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":0.9269999861717224},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.996999979019165},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.996999979019165},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8550000190734863},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.8740000128746033},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.7020000219345093},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.957737922668457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9039687514305115},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6825898289680481},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6574641466140747},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.643047571182251},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5521539449691772},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.5291597843170166},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5172253847122192},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46891555190086365},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4458504319190979},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.38949960470199585},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.36783337593078613},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35944318771362305},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.32588687539100647},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2574896514415741},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22732222080230713}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/17474086.2016.1170593","doi":"https://doi.org/10.1586/17474086.2016.1170593","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17474086.2016.1170593","pdf_url":null,"source":{"id":"https://openalex.org/S73682863","display_name":"Expert Review of Hematology","issn_l":"1747-4086","issn":["1747-4086","1747-4094"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Hematology","raw_type":"journal-article"},{"id":"pmid:27011303","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27011303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":95,"referenced_works":["https://openalex.org/W1198940312","https://openalex.org/W1485389706","https://openalex.org/W1488000644","https://openalex.org/W1514205868","https://openalex.org/W1555553634","https://openalex.org/W1556946899","https://openalex.org/W1822949416","https://openalex.org/W1938144043","https://openalex.org/W1965979673","https://openalex.org/W1967512987","https://openalex.org/W1968939691","https://openalex.org/W1979818745","https://openalex.org/W1981179374","https://openalex.org/W1991184842","https://openalex.org/W1991644988","https://openalex.org/W1996815863","https://openalex.org/W1999624685","https://openalex.org/W2005230107","https://openalex.org/W2005395372","https://openalex.org/W2014467271","https://openalex.org/W2015956932","https://openalex.org/W2019692398","https://openalex.org/W2030107268","https://openalex.org/W2031452426","https://openalex.org/W2037873230","https://openalex.org/W2038414910","https://openalex.org/W2039500930","https://openalex.org/W2043843485","https://openalex.org/W2052920262","https://openalex.org/W2054025347","https://openalex.org/W2058015212","https://openalex.org/W2060244206","https://openalex.org/W2062399441","https://openalex.org/W2066064966","https://openalex.org/W2066991780","https://openalex.org/W2067948267","https://openalex.org/W2068302119","https://openalex.org/W2071383132","https://openalex.org/W2076106584","https://openalex.org/W2095746088","https://openalex.org/W2097995306","https://openalex.org/W2099570622","https://openalex.org/W2106275447","https://openalex.org/W2107925822","https://openalex.org/W2109619078","https://openalex.org/W2112083044","https://openalex.org/W2118241155","https://openalex.org/W2118796952","https://openalex.org/W2120104555","https://openalex.org/W2120366344","https://openalex.org/W2120853229","https://openalex.org/W2122828730","https://openalex.org/W2123755151","https://openalex.org/W2124575836","https://openalex.org/W2124623314","https://openalex.org/W2126960075","https://openalex.org/W2129702476","https://openalex.org/W2130122821","https://openalex.org/W2135802989","https://openalex.org/W2137958124","https://openalex.org/W2138919007","https://openalex.org/W2145822190","https://openalex.org/W2148202982","https://openalex.org/W2148657372","https://openalex.org/W2149699468","https://openalex.org/W2151177887","https://openalex.org/W2162020809","https://openalex.org/W2169000897","https://openalex.org/W2191988482","https://openalex.org/W2210105610","https://openalex.org/W2223191381","https://openalex.org/W2335893186","https://openalex.org/W2460477750","https://openalex.org/W2464665443","https://openalex.org/W2470358294","https://openalex.org/W2496180931","https://openalex.org/W2508162331","https://openalex.org/W2510323643","https://openalex.org/W2530965063","https://openalex.org/W2544051485","https://openalex.org/W2545352579","https://openalex.org/W2547353143","https://openalex.org/W2551369961","https://openalex.org/W2558541011","https://openalex.org/W2560389151","https://openalex.org/W2563838629","https://openalex.org/W2566007460","https://openalex.org/W2570654636","https://openalex.org/W2592851172","https://openalex.org/W2606605688","https://openalex.org/W2751419924","https://openalex.org/W2979535763","https://openalex.org/W2980013397","https://openalex.org/W2980310532","https://openalex.org/W4255309549"],"related_works":["https://openalex.org/W4402258528","https://openalex.org/W7211953207","https://openalex.org/W4361195507","https://openalex.org/W4412402995","https://openalex.org/W2166899683","https://openalex.org/W4417041666","https://openalex.org/W3087202201","https://openalex.org/W2900578072","https://openalex.org/W2762425137","https://openalex.org/W4312620149"],"abstract_inverted_index":{"Recent":[0],"developments":[1],"in":[2,59,62,72,83,120],"immunotherapy":[3,119],"are":[4],"improving":[5,121],"treatment":[6,91,111,122],"results":[7,71],"of":[8,51,87,103,110,117],"B-precursor":[9],"acute":[10],"lymphoblastic":[11],"leukemia.":[12],"This":[13],"advancement":[14],"is":[15,127],"promoted":[16],"by":[17,28,31],"new":[18,81],"monoclonal":[19],"antibodies":[20],"such":[21],"as":[22],"inotuzumab":[23],"ozogamicin,":[24],"ofatumumab":[25],"and":[26,30,44,53,61,93,99,124],"blinatumomab,":[27],"rituximab,":[29],"genetically":[32],"engineered":[33],"chimeric":[34],"antigen":[35],"receptor-modified":[36],"T-cells.":[37],"These":[38],"treatments,":[39],"variously":[40],"targeting":[41],"CD22,":[42],"CD20":[43],"CD19":[45],"antigens,":[46],"yield":[47],"unprecedented":[48],"high":[49],"rates":[50],"hematologic":[52],"molecular":[54,105],"remissions":[55],"even":[56],"when":[57],"used":[58],"monotherapy":[60],"chemo-resistant":[63],"or":[64],"post-transplantation":[65],"relapsed":[66],"patients.":[67],"Beside":[68],"the":[69,84,101,108],"encouraging":[70],"relapsed/refractory":[73],"disease,":[74],"these":[75],"agents":[76],"may":[77],"open":[78],"a":[79,104],"totally":[80],"era":[82],"frontline":[85],"management":[86],"this":[88],"illness,":[89],"redefining":[90],"standards":[92],"options":[94],"for":[95],"different":[96],"risk":[97],"subsets":[98],"placing":[100],"achievement":[102],"remission":[106],"at":[107],"forefront":[109],"objectives.":[112],"The":[113],"ever":[114],"increasing":[115],"importance":[116],"modern":[118],"design":[123],"therapeutic":[125],"outcome":[126],"reviewed.":[128]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}